FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988887263> ?p ?o ?g. }

• W1988887263 endingPage "1602" @default.
• W1988887263 startingPage "1594" @default.
• W1988887263 abstract "Prostate cancer is the most commonly diagnosed malignancy in British men. The increasing use of PSA screening test has resulted in many more patients being diagnosed with this condition. Advances in its treatment have improved the survival rate among these patients. By 2040, the prevalence of prostate cancer survivors is expected to reach 830 000. Many of them will require medical support for the management of their progressive disease or long-term toxicities from previous treatments. Successful implementation of the cancer survivorship programme among these patients depends on a good understanding of their demand on the health care system. The aim of this study is to segment the population of prostate cancer survivors into different needs groups and to quantify them with respect to their phase of care. Incidence, survival, prevalence and mortality data collected and reported by cancer registries across the United Kingdom have been used for the current study to provide indicative estimates as to the number of prostate cancer patients in each phase of the care pathway in a year. The majority of prostate cancer patients are in the post-treatment monitoring phase. Around a fifth of the patients are either receiving treatment or in the recovery and readjustment phase having completed their treatment in the preceding year. Thirteen percent have not received any anticancer treatment, a further 12% (32 000) have developed metastatic disease and 4% are in the final stage of their lives. On the basis of our estimates, patients undergoing post-treatment monitoring phase will constitute the biggest group among prostate cancer survivors. The pressure to provide adequate follow-up care to these patients will be a challenge. There is limited data available to definitively quantify the number of prostate cancer patients who follow different pathways of care, and we hope this study has highlighted the importance of collecting and reporting of such data to help future health care planning for these patients." @default.
• W1988887263 created "2016-06-24" @default.
• W1988887263 creator A5016759319 @default.
• W1988887263 creator A5053298664 @default.
• W1988887263 creator A5075388907 @default.
• W1988887263 creator A5086701474 @default.
• W1988887263 date "2015-03-19" @default.
• W1988887263 modified "2023-10-06" @default.
• W1988887263 title "Using routinely collected data to stratify prostate cancer patients into phases of care in the United Kingdom: implications for resource allocation and the cancer survivorship programme" @default.
• W1988887263 cites W1504213150 @default.
• W1988887263 cites W1565613359 @default.
• W1988887263 cites W1945139963 @default.
• W1988887263 cites W1970690802 @default.
• W1988887263 cites W1971251499 @default.
• W1988887263 cites W1997732940 @default.
• W1988887263 cites W2002783201 @default.
• W1988887263 cites W2003179365 @default.
• W1988887263 cites W2015067306 @default.
• W1988887263 cites W2023169161 @default.
• W1988887263 cites W2030569325 @default.
• W1988887263 cites W2034429188 @default.
• W1988887263 cites W2037785511 @default.
• W1988887263 cites W2064240815 @default.
• W1988887263 cites W2066832261 @default.
• W1988887263 cites W2072633261 @default.
• W1988887263 cites W2073931406 @default.
• W1988887263 cites W2081084828 @default.
• W1988887263 cites W2081667029 @default.
• W1988887263 cites W2089531281 @default.
• W1988887263 cites W2092753808 @default.
• W1988887263 cites W2097695683 @default.
• W1988887263 cites W2098998490 @default.
• W1988887263 cites W2099708627 @default.
• W1988887263 cites W2101001966 @default.
• W1988887263 cites W2101436815 @default.
• W1988887263 cites W2101889062 @default.
• W1988887263 cites W2102818606 @default.
• W1988887263 cites W2107270081 @default.
• W1988887263 cites W2107671263 @default.
• W1988887263 cites W2108183929 @default.
• W1988887263 cites W2110534364 @default.
• W1988887263 cites W2110569728 @default.
• W1988887263 cites W2110881680 @default.
• W1988887263 cites W2121655616 @default.
• W1988887263 cites W2123526148 @default.
• W1988887263 cites W2128883808 @default.
• W1988887263 cites W2129820723 @default.
• W1988887263 cites W2138320929 @default.
• W1988887263 cites W2141198296 @default.
• W1988887263 cites W2141454098 @default.
• W1988887263 cites W2142466432 @default.
• W1988887263 cites W2144574555 @default.
• W1988887263 cites W2145567935 @default.
• W1988887263 cites W2148643283 @default.
• W1988887263 cites W2157996158 @default.
• W1988887263 cites W2164083335 @default.
• W1988887263 cites W2313198760 @default.
• W1988887263 cites W2316095838 @default.
• W1988887263 cites W4239538204 @default.
• W1988887263 doi "https://doi.org/10.1038/bjc.2014.650" @default.
• W1988887263 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4453665" @default.
• W1988887263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25791873" @default.
• W1988887263 hasPublicationYear "2015" @default.
• W1988887263 type Work @default.
• W1988887263 sameAs 1988887263 @default.
• W1988887263 citedByCount "16" @default.
• W1988887263 countsByYear W19888872632016 @default.
• W1988887263 countsByYear W19888872632017 @default.
• W1988887263 countsByYear W19888872632018 @default.
• W1988887263 countsByYear W19888872632019 @default.
• W1988887263 countsByYear W19888872632020 @default.
• W1988887263 countsByYear W19888872632021 @default.
• W1988887263 countsByYear W19888872632023 @default.
• W1988887263 crossrefType "journal-article" @default.
• W1988887263 hasAuthorship W1988887263A5016759319 @default.
• W1988887263 hasAuthorship W1988887263A5053298664 @default.
• W1988887263 hasAuthorship W1988887263A5075388907 @default.
• W1988887263 hasAuthorship W1988887263A5086701474 @default.
• W1988887263 hasBestOaLocation W19888872631 @default.
• W1988887263 hasConcept C120665830 @default.
• W1988887263 hasConcept C121332964 @default.
• W1988887263 hasConcept C121608353 @default.
• W1988887263 hasConcept C126322002 @default.
• W1988887263 hasConcept C143998085 @default.
• W1988887263 hasConcept C172400760 @default.
• W1988887263 hasConcept C177713679 @default.
• W1988887263 hasConcept C2776235491 @default.
• W1988887263 hasConcept C2779134260 @default.
• W1988887263 hasConcept C2779399171 @default.
• W1988887263 hasConcept C2780192828 @default.
• W1988887263 hasConcept C2908647359 @default.
• W1988887263 hasConcept C61511704 @default.
• W1988887263 hasConcept C71924100 @default.
• W1988887263 hasConcept C99454951 @default.
• W1988887263 hasConceptScore W1988887263C120665830 @default.
• W1988887263 hasConceptScore W1988887263C121332964 @default.
• W1988887263 hasConceptScore W1988887263C121608353 @default.
• W1988887263 hasConceptScore W1988887263C126322002 @default.

• next